Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

Details

Language :

English

ISSN :

0732183X

Volume :

34

Issue :

7

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

113324585

Full Text :

https://doi.org/10.1200/JCO.2015.63.9443